Ketorolac Tromethamine Injection, Solution
Product Images NDC 76045-104

17 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 76045-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Structural Formula (Ket0g 0006 01)

Figure 1 Structural Formula (Ket0g 0006 01)
Chemical structure diagrams showing the molecular structures of Ketorolac Tromethamine, including the ketorolac moiety and the tromethamine component, as represented in a typical chemical formula format.*
FDA Label Image

Figure (Ket0g 0006 02)

Figure (Ket0g 0006 02)
A black and white line drawing of a ketorolac tromethamine injection syringe labeled with parts including a removable syringe tip cap, a plastic wrap covering the syringe (marked Do Not Remove), and an external collar (marked Do Not Remove). The syringe barrel shows volume graduations but no specific dosage strength is indicated.*
FDA Label Image

Figure (Ket0g 0006 03)

Figure (Ket0g 0006 03)
An instructional line drawing showing hands holding a syringe and a vial, demonstrating the process of drawing medication from the vial into the syringe. The image likely illustrates preparation steps for an injectable solution.*
FDA Label Image

Figure (Ket0g 0006 04)

Figure (Ket0g 0006 04)
An instructional black-and-white line drawing illustrating the removal of a cap from a syringe or vial. One hand holds the syringe while the other hand twists the cap counterclockwise to open it.*
FDA Label Image

Figure (Ket0g 0006 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Carton Panel)
Packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL, an intramuscular and intravenous injection solution. The label indicates a carton containing 24 prefilled 1 mL single-use syringes. The product is labeled for Rx only and manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 1 mL Blister Pack Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 1 mL Blister Pack Label)
Label for Ketorolac Tromethamine Injection, USP 30 mg/mL in a 1 mL prefilled single-use syringe. The label indicates its use for intravenous or intramuscular administration. Includes storage instructions, lot and expiration placeholders, and barcode. Manufactured by Fresenius Kabi USA, LLC under the Simplist brand.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 1 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 1 mL Syringe Label)
Label for Ketorolac Tromethamine Injection, USP 30 mg/mL solution for injection. It indicates the product is a 1 mL single-use dose for intravenous or intramuscular use. The label includes a volume scale and states it is Rx only, manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 2 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 2 mL Carton Panel)
Carton packaging for Ketorolac Tromethamine Injection USP, 60 mg/2 mL (30 mg/mL) solution for intramuscular injection. The label indicates the product contains 24 prefilled single-use 2 mL syringes. The labeler is Fresenius Kabi USA, LLC. The carton includes warnings for intramuscular use only and disposal instructions for unused portions.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 2 mL Blister Pack Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine 2 mL Blister Pack Label)
Label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) solution for intramuscular injection. The label specifies it is a 2 mL prefilled single-use syringe, intended for intramuscular use only. It includes storage instructions to keep at 20° to 25°C and protect from light. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac 2 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac 2 mL Syringe Label)
Label of Ketorolac Tromethamine injection, USP, showing a 2 mL single-use vial with strength 60 mg/2 mL (30 mg/mL). The label specifies intramuscular use only and includes a dosage scale in milliliters, barcode, and is marked for prescription use. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Carton Panel)
Packaging label for Ketorolac Tromethamine Injection, USP 15 mg/mL solution for intravenous or intramuscular use. The label indicates a package containing 24 prefilled single-use 1 mL syringes. The labeler is Fresenius Kabi USA, LLC. Instructions include discarding unused portions and not placing the syringe on a sterile field.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Blister Pack Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac 1 mL Blister Pack Label)
Label for Ketorolac Tromethamine Injection USP 15 mg/mL in a 1 mL prefilled single-use syringe by Fresenius Kabi USA, LLC. The injection is indicated for intravenous or intramuscular use. Storage instructions advise keeping at 20° to 25°C, protecting from light, and retaining the carton until use. Lot and expiration date fields are present but not filled.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine  1 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY - Ketorolac Tromethamine  1 mL Syringe Label)
Label of Ketorolac Tromethamine Injection, USP 15 mg/mL solution for injection by Fresenius Kabi. The label indicates a 1 mL single-use syringe for intravenous (IV) or intramuscular (IM) use, with volume markings and a barcode present.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Carton Panel)
Packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL, an intramuscular and intravenous solution. The label indicates a package containing 24 prefilled 1 mL single-use syringes. The labeler is Fresenius Kabi USA, LLC. The label includes instructions to discard unused portions and warnings about not placing syringes on sterile fields.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Blister Pack Label)

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Blister Pack Label)
Label for Ketorolac Tromethamine Injection USP, 30 mg/mL, a 1 mL prefilled single-use syringe for intravenous or intramuscular use. The label includes storage instructions, usage directions, manufacturer Fresenius Kabi USA, LLC, and typical placeholders for expiration date, lot number, and barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Syringe Label)
Label for Ketorolac Tromethamine Injection, USP 30 mg/mL, a human prescription intramuscular injection solution. The label includes volume markings up to 1 mL, indicates single-use for IV or IM use, and features a barcode and Fresenius Kabi branding with RFID symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.